RAPT Therapeutics, Inc. Current Liabilities
RAPT Therapeutics, Inc. had Current Liabilities of $13.38 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-11-06
- 2025-09-30: Liabilities, Current $13.38M.
- 2025-06-30: Liabilities, Current $13.04M.
- 2025-03-31: Liabilities, Current $8.68M.
- 2024-12-31: Liabilities, Current $48.35M.
| Period end | Liabilities, Current |
|---|---|
| 2025-09-30 | $13.38M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $13.04M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $8.68M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $48.35M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $10.36M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $14.80M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $21.17M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $21.84M 10-K · filed 2025-03-06 |
| 2023-09-30 | $21.85M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $15.41M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $21.61M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $14.22M 10-K · filed 2024-03-07 |
| 2022-09-30 | $13.87M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $13.15M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $12.36M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $9.60M 10-K · filed 2023-03-14 |
| 2021-09-30 | $12.70M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $10.39M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $11.14M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $11.74M 10-K · filed 2022-03-10 |
| 2020-09-30 | $15.59M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $13.08M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $13.44M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $9.26M 10-K · filed 2021-03-11 |
| 2019-09-30 | $5.46M 10-Q · filed 2019-12-11 |
| 2018-12-31 | $4.64M 10-K · filed 2020-03-30 |